Endovascular treatment of septic thrombophlebitis: a case report of a rare complication and review of the literature

Schifferdecker, Branislav; Merchan, Juan; Ahmar, Corinne; Worthington, Michael; Griben, Andre; Schainfeld, Robert M.; Soukas, Peter

doi:10.1177/1358863x08096517

Cited by 11 publications

(4 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Volkow et al 3 used another thrombolysis agent (streptokinase) with an infusion rate ranging from 20 000 to 40 000 IU h −1 , using a bolus at the start of the thrombolysis (250 000 IU). This regimen was found to be successful in the treatment of 3 patients Schifferdecker et al 4 also reported better efficacy using in situ thrombolysis compared to general thrombolysis. This treatment regimen provides a combinatorial advantage as it removes both the thrombus and the source of infection while also lowering the thrombolysis agent dosage required, thereby reducing the risk of bleeding.…”

Section: Discussionmentioning

confidence: 94%

Septic Thrombophlebitis with Persistent Bacteremia Treated by Thrombolysis

Farny¹,

Vacheron²,

Friggeri³

et al. 2022

Turk J Anaesthesiol Reanim

View full text Add to dashboard Cite

Septic thrombophlebitis requires both adapted antimicrobial therapy and control of the source of the infection. The source of the infection is generally controlled through adequate management of anticoagulation. In this study, we present the case of a 50 years old woman, with septic thrombophlebitis of a peripherally inserted central catheters line and with persistent bacteremia and thrombus, where in situ thrombolysis has successfully removed the thrombus.

show abstract

Section: Discussionmentioning

confidence: 94%

Septic Thrombophlebitis with Persistent Bacteremia Treated by Thrombolysis

Farny¹,

Vacheron²,

Friggeri³

et al. 2022

Turk J Anaesthesiol Reanim

View full text Add to dashboard Cite

show abstract

“…2) It has also been reported in patients with salmonella bacteremia secondary to osteomyelitis. 3,4) It is well recognized that intravenous drug abusers (IVDA) commonly present with skin or subcutaneous abscesses and suppurative thrombophlebitis of small veins. This often happens when attempting unsterile access to peripheral veins.…”

Section: Discussionmentioning

confidence: 99%

A Rare Case of Septic Deep Vein Thrombosis in the Inferior Vena Cava and the Left Iliac Vein in an Intravenous Drug Abuser

Koh

Ch’ng

Tan

2012

Annals of Vascular Diseases

View full text Add to dashboard Cite

“…PE is one of the foremost causes of cardiovascular mortality, overtaken only by stroke and acute myocardial infarction [2]. The interplay between Salmonellae and the development of thrombosis has been known for more than a century, and subsequent studies have confirmed that acute infections are a risk factor for subsequent VTE [3][4][5][6][7][8]. Several animal models have shown the impact of bacterial infections on subsequent inflammation and coagulation in vivo.…”

Section: Introductionmentioning

confidence: 99%

The Risk of Subsequent Deep Vein Thrombosis and Pulmonary Embolism in Patients with Nontyphoidal Salmonellosis: A Nationwide Cohort Study

Chang

Wei

et al. 2020

IJERPH

View full text Add to dashboard Cite

The purpose of this study was to evaluate the deep vein thrombosis (DVT) and pulmonary embolism (PE) risk among patients with a diagnosis of nontyphoidal salmonellosis (NTS) in an Asian population. The risk was analyzed in a cohort of 17,855 patients newly diagnosed with NTS and 71,420 individuals without NTS using a hospitalization claim dataset. Both groups were matched by age, sex, and index date as an original analysis. A Cox proportional-hazards regression model was applied to estimate the risk of DVT and PE, accounting for any competing event (death). With a follow-up of 4.94 (±3.93) years in the NTS group and 6.30 (±3.67) years in the non-NTS group, the adjusted subhazard ratios (SHRs) of DVT and PE were 1.83 (95% CI 1.44–2.31) and 1.84 (95% CI 1.30–2.60). The NTS group had an increased risk of DVT and PE compared with the control group in all of the age subgroups. Stratified analyses showed that patients aged 18–39 years in the NTS group had significantly higher DVT and PE risks compared with patients of the same age in the non-NTS group (aHR, 5.95; 95% CI, 2.22–15.91 for DVT; aHR 6.72; 95% CI, 2.23–20.30 for PE). The P-value for interaction between age and exposure of NTS is <0.001 for DVT and 0.004 for PE in our sub-group analyses. The findings were cross-validated by a re-analysis with propensity score matching (PSM), and that revealed consistent results. Despite of low absolute risk, clinicians should be aware that patients with an NTS hospitalization history is at increased risk for VTE especially when assessing patients coincident with other VTE risk factors.

show abstract

Endovascular treatment of septic thrombophlebitis: a case report of a rare complication and review of the literature

Cited by 11 publications

References 13 publications

Septic Thrombophlebitis with Persistent Bacteremia Treated by Thrombolysis

Septic Thrombophlebitis with Persistent Bacteremia Treated by Thrombolysis

A Rare Case of Septic Deep Vein Thrombosis in the Inferior Vena Cava and the Left Iliac Vein in an Intravenous Drug Abuser

The Risk of Subsequent Deep Vein Thrombosis and Pulmonary Embolism in Patients with Nontyphoidal Salmonellosis: A Nationwide Cohort Study

Contact Info

Product

Resources

About